NEWS

Direct to Angio Suite Triage for Faster Treatment

Angioplasty with stenting and Thrombectomy

Phenox GmbH expands with opening of new UK office.

Bochum, 10th February 2021. Despite a challenging year 2020, Phenox GmbH is pursuing its strategic plans in strengthening the footprint in key markets across Europe. As part of this strategy and in the light of Brexit, Phenox has taken the decision to open a UK entity materialising in its new office south of Birmingham.

Transcranial embolization of a superficial DAVF

MASTERCLASS - I am a leptomeningeal dural malformation: what does that mean? How do you treat me?

Early Clinical Experience with FRED™ X

Vesalio Receives Peripheral FDA 510k Clearance and Additional CE Approval

Nashville, TN, January 28, 2021 Vesalio reports it has obtained an FDA 510k clearance and its 4th CE approval.  The FDA 510k indication is for the removal of thrombi in peripheral blood vessels. The new CE approval expands the NeVa™ neuro-thrombectomy portfolio. Vesalio’s Drop ZoneTM technology, designed to remove the full spectrum of clots from vascular anatomy, has been acclaimed for consistently achieving high first-pass rates, a key parameter associated with better patient outcomes in stroke.

MASTERCLASS - Is the carotid siphon the private turf of the flow-diverter?

MASTERCLASS - Attacking a tandem stroke: a strategic or technical concern or both?

Double microcatheter technique for ruptured MCA aneurysm